Arbutus Biopharma Corporation (I9DN.F)
Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
At close: 08:06AM CEST
| Previous close | 2.5760 |
| Open | 2.4540 |
| Bid | 2.5080 x 100000 |
| Ask | 2.5520 x 100000 |
| Day's range | 2.4540 - 2.4540 |
| 52-week range | 1.5540 - 2.9380 |
| Volume | |
| Avg. volume | 218 |
| Market cap | 455.072M |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.3900 |
| Earnings date | 01 Aug 2024 - 05 Aug 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 5.90 |
Insider MonkeyArbutus Biopharma Corporation (NASDAQ:ABUS) Q1 2024 Earnings Call Transcript
Arbutus Biopharma Corporation (NASDAQ:ABUS) Q1 2024 Earnings Call Transcript May 2, 2024 Arbutus Biopharma Corporation misses on earnings expectations. Reported EPS is $-0.10178 EPS, expectations were $-0.1. Arbutus Biopharma Corporation isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day, […]
Simply Wall St.Arbutus Biopharma First Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag
Arbutus Biopharma ( NASDAQ:ABUS ) First Quarter 2024 Results Key Financial Results Revenue: US$1.53m (down 77% from 1Q...
- GuruFocus.com
Arbutus Biopharma Corp (ABUS) Q1 2024 Earnings Call Transcript Highlights: Strategic ...
Insights into Arbutus Biopharma Corp's Q1 performance, including financial updates and progress in clinical trials.
© 2024 Yahoo. All rights reserved.